The association between the health promotion levy and employment in South Africa: an interrupted time series analysis | BMC Nutrition

The Rising Tide of Sugar-Sweetened Beverage Taxes Sugar-sweetened beverage (SSB) taxes have emerged as a pivotal policy tool in the fight against obesity and related non-communicable diseases. These taxes, initiated in various countries across the globe, aim to curtail the consumption of sugary drinks by making them less financially attractive. A recent study by Lara-Castor … Read more

Can an online lifestyle plan keep your brain sharp? Research says yes

Exploring the Future of Digital Cognitive Health The modern digital landscape presents fascinating opportunities for health innovation. Among the most promising lies in leveraging technology to preserve brain health. As the population ages, concerns about dementia and cognitive decline are escalating. Yet, emerging research, as highlighted by a study published in Nature Medicine, indicates that … Read more

Bariatric surgery reduces liver complications in obese patients with cirrhosis

The Promising Impact of Bariatric Surgery on Liver Health Recent findings published in *Nature Medicine* highlight the significant potential of bariatric surgery in reducing liver-related complications among patients with obesity and compensated cirrhosis. According to a study led by Ali Aminian, M.D., from Cleveland Clinic, bariatric surgery can lower the risk of serious liver disease … Read more

Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide

Unveiling the Future of Weight-Loss Medication: Balancing Efficacy and Safety The recent surge in the popularity of weight-loss medications, such as semaglutide (Ozempic), brings with it both promises and precautions. These drugs have shown remarkable efficacy in reducing weight, but emerging concerns about their potential side effects, particularly muscle loss, including heart muscle, have raised … Read more

At 97 kg, she joined a clinical trial that redefines obesity. Now at 70 kg, this 48-year-old has reversed risks with a new protocol | Health and Wellness News

The Evolving Definition of Obesity The traditional measure of obesity, BMI, is being re-evaluated to better encompass diverse populations. For example, the new guidelines incorporate waist circumference and waist-to-hip ratio, addressing abdominal obesity directly associated with severe health issues like heart disease and diabetes.[1] This shift aligns with the Lancet Commission’s view of obesity as … Read more

Large Weight Swings Risky in CVD Patients With Obesity

The Impact of Weight Changes on Health In recent findings, researchers have spotlighted how significant weight fluctuations can impact individuals with obesity and cardiovascular disease (CVD). Probing the data from the UK Biobank over 13.9 years, they discovered that either large weight gain or loss correlates with increased risks of cardiovascular death and all-cause mortality. … Read more

Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”

The Future of GLP-1RA Drugs and Their Implications As the demand for weight-loss medications continues to surge, GLP-1RA drugs like Ozempic and Wegovy are emerging as a revolutionary treatment option. These “miracle drugs” promise significant health benefits, including weight loss, improved brain health, and reduced addiction risks. However, there are also associated risks that emphasize … Read more

Maternal vitamin D deficiency may accelerate fetal aging and impact newborn health

Unveiling the Impact of Maternal Vitamin D on Fetal Health A recent study from the National Center for Child Health and Development in Tokyo has revealed a critical link between low maternal vitamin D levels and accelerated fetal biological clocks. As research delves into the implications of vitamin D deficiency, it raises important questions about … Read more

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

The Evolving Role of GLP1RA in Diabetes Management and Mental Health As the use of GLP1RA—glucagon-like peptide 1 receptor agonists—grows in managing type 2 diabetes and obesity, there is increasing interest in their behavioral side effects. Recent research published in Diabetes, Obesity and Metabolism offers an in-depth look at these potential side effects and offers … Read more

Jan 17 2025 This Week in Cardiology

Renal Denervation: The Future of Hypertension Treatment? Renal denervation (RDN), a procedure aimed at lowering blood pressure by disrupting nerves in the kidney, has faced mixed reviews. Despite regulatory approval from the FDA, its efficacy remains contentious. Recent discussions have spotlighted the need for higher standards in trial designs to validate such treatments. The future … Read more